Abstract
Peripheral neuropathy is a common and debilitating condition with a prevalence of 2% to 7% in the general population.1,2 The prevalence increases significantly in older adults, with a prevalence of approximately 15% in those older than 40 years.3 Distal symmetric polyneuropathy (DSP) is the most common subtype of neuropathy.4 Previous research suggests that a focused and directed evaluation is the optimal diagnostic approach in this patient population.5 The best evidence for diagnostic testing in DSP was recently summarized in a systematic review by the American Academy of Neurology (AAN).4 Fasting glucose levels, vitamin B12 levels, serum protein electrophoresis (SPEP), and 2-hour oral glucose tolerance tests (GTTs) were supported by the literature based on the yield of these tests and the potential for subsequent interventions.4 A fasting glucose level is the most frequently used test to diagnose diabetes, which is the most common cause of DSP.6 Vitamin B12 deficiency causes a potentially treatable neuropathy with different characteristics than those in idiopathic neuropathy.7 The use of GTTs and SPEP is supported by evidence8-10 that patients with neuropathy have a substantially increased prevalence of these abnormalities compared with control groups. Evidence to support other diagnostic tests in the evaluation of DSP is lacking.

This publication has 18 references indexed in Scilit: